(DCNF)—Persistent levels of spike protein from COVID-19 vaccines could be associated with a range of chronic symptoms like excessive fatigue, brain fog and muscle aches, according to a Yale University study published Wednesday.
The study describes these symptoms and others — including tingling and numbness, exercise intolerance and difficulty concentrating — as post-vaccine syndrome or PVS. Other symptoms included trouble falling or staying asleep, nerve damage, muscle aches, anxiety, tinnitus and burning sensations. The study was published as a preprint, meaning it has not yet found a home in a scientific journal and has yet to be vetted by outside scientists via peer review.
The researchers studied 42 individuals they diagnosed with PVS. The researchers tested for dozens of potential biological signatures of the syndrome using serology, or blood tests, uncovering a range of hypotheses about the underlying causes.
The researchers hesitated to pinpoint any one single cause, emphasizing that further studies are needed.
But perhaps the most striking clue the researchers picked up was significantly higher circulating levels of spike protein as compared to the control group. Individuals vaccinated 600 to 700 days prior had more elevated levels of spike protein than other participants who had been vaccinated more recently.
However the study only measured each individual’s spike protein levels once, thus could not determine whether the spike protein was increasing over time.
“This suggested that prolonged antigen persistence might be associated with PVS in a subgroup of patients,” the study reads.
The study included participants who had received the Pfizer, Moderna and Johnson & Johnson shots.
JD’s manually curated links for God-fearing MAGA patriots
Another potential signal of the syndrome explored in the paper is T cell exhaustion — when white blood cells progressively lose the ability to fight off infections. People with PVS also had fewer antibodies against the spike protein as compared to the control group. It’s also possible that the syndrome is associated with a reactivation of dormant Epstein-Barr virus (EBV), a common and usually latent virus.
The researchers acknowledged that PVS has been neglected by health authorities, as many consider the topic “radioactive.”
“This is a hard topic to study. People don’t want to fund it and journals don’t want to publish it because it is viewed as radioactive and I’m so grateful to my co-authors for staying the course,” said David Putrino, director of Rehabilitation Innovation for the Mount Sinai Health System and a coauthor of the paper, in an X thread. “To anyone saying that this paper will embolden antivax movements, please take a moment to consider an alternate take: failing to be transparent in the moment, denying the lived experience of many and hiding the truth is what emboldens anti-science movements. In the history of drug discovery, there has never been a drug that didn’t produce side effects in a percentage of users. Pretending this fact isn’t real is dishonest.”
Yet some in the scientific community criticized the scientists for publishing the preprint at all.
The study drew data from the Yale School of Medicine’s Listen to Immune, Symptom and Treatment Experiences Now (LISTEN) study, as well as the Centre for Post COVID Care at Mount Sinai Hospital.
The PVS group had poorer health and a poorer quality of life than average, despite the cohort having no preexisting comorbidities and being relatively young (median age 43).
Long COVID shares many of the same symptoms of PVS, the researchers wrote, though there are some differences. While long COVID can be associated with elevated SARS-CoV-2 antibodies, the individuals with PVS in the new study had lower antibodies than the control group.
The preprint states that the condition afflicts a small fraction of people receiving COVID-19 vaccines. The researchers were quick to emphasize that the COVID-19 vaccines saved lives.
“By revealing distinct immunological features of PVS, this study helped generate hypotheses regarding the underlying pathobiology of this condition,” the study reads. “Understanding such mechanisms will help improve the overall safety profile of COVID-19 vaccines and support public health strategies that maximize vaccine efficacy while minimizing adverse effects.”
The study arrives amid Robert F. Kennedy Jr.’s first days at the helm of the Department of Health and Human Services.
His ascension to the role of HHS secretary could prompt a second look at policies promulgated by the Biden administration around the COVID-19 vaccine, including the decision to mandate vaccination of some individuals with a previous COVID-19 infection as a precondition for employment.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.